Welcome to our dedicated page for Synopsys SEC filings (Ticker: SNPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Synopsys, Inc. (SNPS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Synopsys common stock is registered on the Nasdaq Global Select Market, and the company regularly uses Form 8-K and other filings to report material events, financial results, and governance changes. These documents are central resources for understanding how Synopsys presents its business segments, strategic actions, and risk factors to investors.
Recent 8-K filings illustrate several themes that may be of interest to shareholders and analysts. One filing reports a restructuring plan approved by the board of directors, which is expected to affect approximately 10% of the workforce as of fiscal 2025 year-end. Synopsys states that this plan is intended to support investment in key growth opportunities and drive business efficiencies following the completion of its acquisition of Ansys, Inc., with substantial completion expected by the end of fiscal year 2027, subject to local requirements.
Other 8-Ks disclose topics such as the departure or appointment of certain officers, reaffirmation of financial targets, and the announcement of quarterly financial results. In its earnings-related filings and press releases, Synopsys reports revenue and net income on both GAAP and non-GAAP bases, provides reconciliations, and explains adjustments related to amortization of acquired intangible assets, stock-based compensation, acquisition and divestiture items, restructuring charges, and tax effects.
Filings also document regulatory and export control developments. For example, Synopsys reported receiving a letter from the U.S. Department of Commerce’s Bureau of Industry and Security rescinding previously imposed export restrictions related to China, and noted that it is working to restore access to affected products while assessing the impact of such restrictions on its business. Forward-looking statements sections in these filings outline risks and uncertainties related to macroeconomic conditions, industry trends, acquisitions, export controls, and other factors.
Through Stock Titan, users can review these SEC documents alongside AI-powered summaries that highlight key items such as restructuring plans, segment disclosures, export control updates, and earnings metrics. This helps readers quickly identify the portions of Synopsys’ 8-Ks, 10-Ks, 10-Qs, and related filings that are most relevant to their analysis of SNPS.
Synopsys (SNPS) – Form 4 insider update
On 31 Jul 2025 Director Ajei Gopal converted 117,256 restricted stock units into common shares at a $0 exercise price. To cover tax obligations, 46,153 shares were automatically withheld and sold back to the company at $633.47, a transaction valued at roughly $29.3 million. Net of withholding, his direct ownership rose by 71,103 shares, taking his total stake to 166,606 shares.
Per the separation agreement cited in the filing, all of Gopal’s remaining unvested RSUs were accelerated and vested in connection with his termination of employment. The dispositions were strictly for tax-withholding purposes; no open-market sales were reported.